This inventor holds 1 USPTO granted patent. Top assignees: Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Leibniz-Institut Fur Pflanzenbiochemie. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Carlos A Guzmán: Innovator in Immune Stimulation
Introduction
Carlos A Guzmán is a notable inventor based in Wolfenbüttel, Germany. He has made significant contributions to the field of immune stimulation through his innovative research and patents. His work focuses on the development of phytosphingosine derivatives that serve as adjuvants in immune responses.
Latest Patents
Guzmán holds a patent for "Phytosphingosine derivatives as adjuvants in immune stimulation." This patent describes phytosphingosine derivatives that are suitable for use in pharmaceutical compositions aimed at stimulating immune responses in subjects. The compounds can be utilized in therapeutic or prophylactic methods to treat diseases where immune response stimulation is beneficial. Additionally, these derivatives can aid in antibody production, combat infections, and even prevent or treat septic shock. The patent also details methods for manufacturing these derivatives using an Ugi-4-component reaction.
Career Highlights
Throughout his career, Carlos A Guzmán has worked with esteemed institutions such as the Leibniz Institute for Plant Biochemistry and the Helmholtz Centre for Infection Research. His research has been pivotal in advancing the understanding of immune stimulation and the development of new therapeutic strategies.
Collaborations
Guzmán has collaborated with notable colleagues, including Bernhard Westermann and Ludger A Wessjohann. These partnerships have contributed to the success of his research and the impact of his inventions in the scientific community.
Conclusion
Carlos A Guzmán is a distinguished inventor whose work in immune stimulation through phytosphingosine derivatives has the potential to revolutionize therapeutic approaches. His contributions to science and medicine continue to inspire innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile